Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower risk myelodysplastic syndromes. Somatic mutations and DNA methylation identify a subgroup of poor prognosis within lower risk myelodysplastic syndromes

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series